PT3159335T - Novo composto heterocíclico - Google Patents

Novo composto heterocíclico

Info

Publication number
PT3159335T
PT3159335T PT158123828T PT15812382T PT3159335T PT 3159335 T PT3159335 T PT 3159335T PT 158123828 T PT158123828 T PT 158123828T PT 15812382 T PT15812382 T PT 15812382T PT 3159335 T PT3159335 T PT 3159335T
Authority
PT
Portugal
Prior art keywords
heterocyclic compound
novel heterocyclic
novel
compound
heterocyclic
Prior art date
Application number
PT158123828T
Other languages
English (en)
Original Assignee
Dae Woong Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dae Woong Pharma filed Critical Dae Woong Pharma
Publication of PT3159335T publication Critical patent/PT3159335T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT158123828T 2014-06-23 2015-06-23 Novo composto heterocíclico PT3159335T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20140076674 2014-06-23

Publications (1)

Publication Number Publication Date
PT3159335T true PT3159335T (pt) 2020-06-05

Family

ID=54938901

Family Applications (1)

Application Number Title Priority Date Filing Date
PT158123828T PT3159335T (pt) 2014-06-23 2015-06-23 Novo composto heterocíclico

Country Status (18)

Country Link
US (1) US10081634B2 (pt)
EP (1) EP3159335B1 (pt)
JP (1) JP6272510B2 (pt)
KR (1) KR102276340B1 (pt)
CN (1) CN106458923B (pt)
AU (1) AU2015280874B2 (pt)
CA (1) CA2951798C (pt)
ES (1) ES2795368T3 (pt)
HR (1) HRP20200785T1 (pt)
HU (1) HUE049482T2 (pt)
MY (1) MY174343A (pt)
NZ (1) NZ727715A (pt)
PH (1) PH12016502568A1 (pt)
PL (1) PL3159335T3 (pt)
PT (1) PT3159335T (pt)
RS (1) RS60264B1 (pt)
SI (1) SI3159335T1 (pt)
WO (1) WO2015199418A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102277538B1 (ko) * 2015-06-08 2021-07-14 주식회사 대웅제약 신규한 헤테로 고리 화합물, 이의 제조 방법 및 이를 포함하는 약학적 조성물
JP2019196308A (ja) * 2016-09-15 2019-11-14 武田薬品工業株式会社 複素環アミド化合物
AR110963A1 (es) * 2017-02-07 2019-05-22 Dae Woong Pharma Compuestos heterocíclicos, su método de preparación y composición farmacéutica que los comprende
KR20240051066A (ko) * 2022-10-12 2024-04-19 주식회사 대웅제약 신장염의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9284297B2 (en) * 2008-08-11 2016-03-15 President And Fellows Of Harvard College Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
WO2010096170A2 (en) * 2009-02-19 2010-08-26 President And Fellows Of Harvard College Inhibition of trna synthetases and therapeutic applications thereof
JP2015506363A (ja) 2012-01-13 2015-03-02 プレジデント アンド フェローズ オブ ハーバード カレッジ ハロフジノール誘導体、および化粧料組成物および医薬組成物におけるその使用
KR102277538B1 (ko) 2015-06-08 2021-07-14 주식회사 대웅제약 신규한 헤테로 고리 화합물, 이의 제조 방법 및 이를 포함하는 약학적 조성물

Also Published As

Publication number Publication date
AU2015280874B2 (en) 2017-12-14
CA2951798C (en) 2018-07-24
MY174343A (en) 2020-04-09
EP3159335A2 (en) 2017-04-26
RS60264B1 (sr) 2020-06-30
EP3159335B1 (en) 2020-04-29
KR20150146462A (ko) 2015-12-31
EP3159335A4 (en) 2017-11-15
US20170088551A1 (en) 2017-03-30
WO2015199418A3 (ko) 2016-04-14
HRP20200785T1 (hr) 2020-08-07
PH12016502568B1 (en) 2017-04-17
KR102276340B1 (ko) 2021-07-12
JP2017520539A (ja) 2017-07-27
PH12016502568A1 (en) 2017-04-17
CN106458923B (zh) 2019-09-10
NZ727715A (en) 2017-09-29
PL3159335T3 (pl) 2020-10-05
WO2015199418A2 (ko) 2015-12-30
ES2795368T3 (es) 2020-11-23
SI3159335T1 (sl) 2020-07-31
CN106458923A (zh) 2017-02-22
CA2951798A1 (en) 2015-12-30
US10081634B2 (en) 2018-09-25
HUE049482T2 (hu) 2020-09-28
JP6272510B2 (ja) 2018-01-31
AU2015280874A1 (en) 2017-01-12

Similar Documents

Publication Publication Date Title
HK1223100A1 (zh) 雜環化合物
IL247018A0 (en) Heterocyclic compound
IL246838A0 (en) A fused heterocyclic compound
EP3187497A4 (en) Heterocyclic compound
GB201417002D0 (en) Novel compound
EP3205645A4 (en) Heterocyclic compound
IL285105A (en) Heterocyclic compound
AP2016009432A0 (en) Novel compounds
EP3192791A4 (en) Heterocyclic compound
GB201405991D0 (en) Novel compounds
GB201411236D0 (en) Novel compounds
GB201411239D0 (en) Novel compounds
GB201404002D0 (en) Novel compounds
GB201413695D0 (en) Compound
GB201412238D0 (en) Compound
EP3239150A4 (en) Heterocyclic compound
SI3159335T1 (sl) Nova heterociklična spojina
IL254890B (en) The tercyclic compound
GB201407694D0 (en) Compound
GB201419102D0 (en) Novel compounds
GB201407506D0 (en) Novel compound
EP3210971A4 (en) Heterocyclic compound
GB201418709D0 (en) Compound
GB201407693D0 (en) Compound
GB201416988D0 (en) Novel compound